Retinitis pigmentosa mental retardation deafness
Retinitis Pigmentosa Mental Retardation Deafness (RPMD) is a rare genetic disorder characterized by a triad of retinitis pigmentosa, mental retardation, and deafness. This condition is part of a group of syndromes that affect multiple body systems, known as syndromic retinitis pigmentosa. Retinitis pigmentosa (RP) refers to a group of genetic disorders that result in progressive peripheral vision loss and night vision difficulties, eventually leading to central vision loss. The mental retardation aspect of RPMD varies in severity among affected individuals, impacting cognitive development and learning abilities. Deafness in RPMD typically presents as sensorineural hearing loss, which may range from mild to profound.
Symptoms and Diagnosis[edit | edit source]
The primary symptoms of RPMD include the progressive loss of vision due to retinitis pigmentosa, cognitive impairment, and hearing loss. The onset of these symptoms can vary, but they often begin in childhood. Diagnosis of RPMD involves a comprehensive evaluation, including a detailed family history, clinical examination, genetic testing, electroretinogram (ERG) to assess retinal function, and audiometric tests to evaluate hearing.
Genetics[edit | edit source]
RPMD is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific genes involved in RPMD can vary, contributing to the diversity in the presentation and severity of symptoms among affected individuals.
Management and Treatment[edit | edit source]
There is currently no cure for RPMD. Management of the condition is focused on addressing the individual symptoms and improving the quality of life for those affected. This may include the use of low vision aids, orientation and mobility training for vision loss, special education programs for cognitive impairment, and hearing aids or cochlear implants for deafness. Regular follow-up with a multidisciplinary team of healthcare providers is essential for monitoring the progression of symptoms and adjusting the management plan as needed.
Prognosis[edit | edit source]
The prognosis for individuals with RPMD varies depending on the severity of the symptoms and the effectiveness of management strategies. While the condition can significantly impact the quality of life, with appropriate support, many individuals with RPMD can lead fulfilling lives.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD